Neil F. McFarlane - Feb 13, 2025 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role
President and CEO, Director
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Neil F. McFarlane
Stock symbol
ZVRA
Transactions as of
Feb 13, 2025
Transactions value $
-$727,390
Form type
4
Date filed
2/14/2025, 05:54 PM
Previous filing
Feb 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Sale -$481K -61.3K -21.63% $7.86 222K Feb 13, 2025 Direct F1
transaction ZVRA Common Stock Sale -$246K -30.5K -13.75% $8.05 192K Feb 14, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Adoption date of referenced 10b5-1(c) plan is: 10-15-2024